Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for ImmunoGen, Inc. (IMGN)

« Back to company index

IMGN Chatter Timeline

Stock Ticker for IMGN

Most Active Tweeters for IMGN

UserTweets
@FlashAlert_me 6
@Gambiste1 3
@AmericanBanking 3
@StockPyf 2
@TopStockAlerts1 2

Recent Tweets for IMGN

StockPyf @StockPyf
Take a look at this Watchlist: $IMGN $ZIOP This is a Filter ScannerAlert scnPennyADTM DateTime: 2019-07-15 09:40 ET
July 15th 2019, 9:07am
AmericanBanking @AmericanBanking
ImmunoGen, Inc. $IMGN Given Consensus Recommendation of “Hold” by Analysts https://t.co/JrAqX762iG #stocks
July 14th 2019, 2:07am
AmericanBanking @AmericanBanking
-$0.32 Earnings Per Share Expected for ImmunoGen, Inc. $IMGN This Quarter https://t.co/XAmPUaAku9 #stocks
July 13th 2019, 10:07am
Gambiste1 @Gambiste1
RT @TekATL3: $IMGN may share. Currently got a small db above where a longer term db set would be, but holding up here atm https://t.co/pxr…
July 13th 2019, 1:07am
TekATL3 @TekATL3
$IMGN may share. Currently got a small db above where a longer term db set would be, but holding up here atm https://t.co/pxrSQVb16t
July 13th 2019, 1:07am
Gambiste1 @Gambiste1
RT @StockPyf: Take a look at this Watchlist: $IMGN This is a Filter ScannerAlert scnPennyADTM DateTime: 2019-07-12 10:25 ET
July 12th 2019, 11:07am
StockPyf @StockPyf
Take a look at this Watchlist: $IMGN This is a Filter ScannerAlert scnPennyADTM DateTime: 2019-07-12 10:25 ET
July 12th 2019, 10:07am
ez_alertz @ez_alertz
$IMGN Will ImmunoGen Continue to Surge Higher? https://t.co/krGXAM4LdU
July 12th 2019, 9:07am
dispatchtribune @dispatchtribune
ImmunoGen $IMGN Upgraded by BidaskClub to “Sell” https://t.co/1xAnVu9FKv
July 10th 2019, 2:07am
ThisLincolnian @ThisLincolnian
ImmunoGen $IMGN Upgraded by BidaskClub to “Sell” https://t.co/i2TmWLlGdU
July 10th 2019, 2:07am
WeekHerald @WeekHerald
ImmunoGen $IMGN Upgraded to “Sell” by BidaskClub https://t.co/7bmaMDCOmu
July 10th 2019, 2:07am
ZolmaxNews @ZolmaxNews
ImmunoGen $IMGN Trading Up 7.4% https://t.co/FtR7Rf5rBZ
July 9th 2019, 11:07pm
TopStockAlerts1 @TopStockAlerts1
$IMGN Liking it for a swing! https://t.co/ZKx6HyHoXo
July 9th 2019, 12:07pm
AmericanBanking @AmericanBanking
Weekly Research Analysts’ Ratings Changes for ImmunoGen $IMGN https://t.co/y9SgZduerU #stocks
July 9th 2019, 4:07am
macondailynews @macondailynews
BidaskClub Upgrades ImmunoGen $IMGN to Sell https://t.co/WfIng26R30
July 9th 2019, 2:07am
TheMarketsDaily @TheMarketsDaily
ImmunoGen $IMGN Upgraded at BidaskClub https://t.co/l3THTRkuzo
July 9th 2019, 2:07am
OlympiaReport @OlympiaReport
ImmunoGen $IMGN Stock Rating Upgraded by BidaskClub https://t.co/hNNMQZ485I
July 8th 2019, 3:07am
TickerReport @TickerReport
ImmunoGen $IMGN Upgraded to “Sell” by BidaskClub https://t.co/TpdJD8FVVk
July 7th 2019, 7:07am
TopStockAlerts1 @TopStockAlerts1
$IMGN keep an eye on it! https://t.co/ZKx6HyHoXo
July 5th 2019, 10:07pm
TimCarmichael3 @TimCarmichael3
@BioStocks $IMGN is Immunogen — not $IMMU Immunomedics
July 5th 2019, 6:07pm
BeefEnt @BeefEnt
ImmunoGen Inc NASDAQ: $IMGN #Drug Health Care : Biotechnology | Small Cap BlendCompany profile BuySell Closing Price $2.25
July 4th 2019, 10:07am
Gambiste1 @Gambiste1
RT @sheldoncrasto88: https://t.co/eeTI6ILW49 Verified $20.08 profit in $IMGN bought this dip buy
July 2nd 2019, 10:07pm
sheldoncrasto88 @sheldoncrasto88
https://t.co/eeTI6ILW49 Verified $20.08 profit in $IMGN bought this dip buy
July 2nd 2019, 8:07pm
SwingTradeBot @SwingTradeBot
50 DMA Support today: $IMGN ... https://t.co/aW7zteKP9U
July 2nd 2019, 3:07pm
InsiderAlertsIA @InsiderAlertsIA
$IMGN: New Insider Filing on Executive VP, General Counsel CRAIG BARROWS: https://t.co/yCpB8ASOUq
July 2nd 2019, 1:07pm
StockTexts @StockTexts
$IMGN ImmunoGen, Inc. SEC Filing: Form 4 https://t.co/S3cleUCJC9
July 2nd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: VP & Chief Medical Officer Berkenblit Anna: Bought 5230 of Common Stock at price 1.84 on 2… https://t.co/NZ8vCaCJTy
July 2nd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: Chief Executive Officer Enyedy Mark J: Bought 5230 of Common Stock at price 1.84 on 2019-0… https://t.co/wu0lIWFydA
July 2nd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: VP, Technical Operations Ryll Thomas: Bought 5230 of Common Stock at price 1.84 on 2019-07… https://t.co/L9EBbGdTpX
July 2nd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: V.P.-Fin., Prin. Acctg. Off. FOSTER DAVID G: Bought 3536 of Common Stock at price 1.84 on… https://t.co/Y563evfc3y
July 2nd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: EVP & Chief Business Officer McKee Blaine H.: Bought 5230 of Common Stock at price 1.84 on… https://t.co/flukvU5HY9
July 2nd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: Executive VP, General Counsel BARROWS CRAIG: Bought 5230 of Common Stock at price 1.84 on… https://t.co/NAGrD6ZuRi
July 2nd 2019, 1:07pm
finzine @finzine
$ATRA $IMGN Citi Finds Biotech Executives Jump Ship Ahead of Bad Drug Trials via https://t.co/dU2ohMb1g7
July 2nd 2019, 10:07am
ConsumerFeed @ConsumerFeed
ImmunoGen $IMGN Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/vr0OQsYtKx
July 2nd 2019, 6:07am
StockSpotter @StockSpotter
$IMGN up 5.5% to 2.29 since our bullish alert Fri. Jun 28 after the bell #swingtrading https://t.co/g8QEozplp6
July 1st 2019, 2:07pm
SolarMelt @SolarMelt
$IMGN In the failed FORWARD-I trial, Mirvetuximab Soravtansine achieved some promising results in high FRa expressi… https://t.co/CMJI30doLN
July 1st 2019, 1:07pm
SolarMelt @SolarMelt
$IMGN A fresh P3 trial of Mirvetuximab Soravtansine (Ovarian Cancer) is expected to begin by year end. This follows… https://t.co/1QSxmwlGJM
July 1st 2019, 1:07pm
InsiderAlertsIA @InsiderAlertsIA
$IMGN: New Insider Filing on Director DEAN J MITCHELL: https://t.co/hXsoWFukjV
July 1st 2019, 10:07am
iamtito_ @iamtito_
$IMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/qXM2AlWz7U
July 1st 2019, 9:07am
iamtito_ @iamtito_
$IMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/3PrMATPJyZ
July 1st 2019, 9:07am
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: Director MITCHELL DEAN J: https://t.co/Sncl59WE5x
July 1st 2019, 9:07am
FlashAlert_me @FlashAlert_me
$IMGN filed SEC form 4: Director Goldberg Mark Alan: https://t.co/tbvDB0BirT
July 1st 2019, 9:07am
TranscriptDaily @TranscriptDaily
HC Wainwright Analysts Give ImmunoGen $IMGN a $4.00 Price Target https://t.co/yp8VAUMlr6
July 1st 2019, 4:07am
TranscriptDaily @TranscriptDaily
ImmunoGen $IMGN Receives “Buy” Rating from Cowen https://t.co/NG8SJi01tp
July 1st 2019, 3:07am
ThisLincolnian @ThisLincolnian
ImmunoGen $IMGN Given “Buy” Rating at Cowen https://t.co/ztb9wEGgw2
June 30th 2019, 7:06am
WeekHerald @WeekHerald
ImmunoGen $IMGN Earns “Buy” Rating from Cowen https://t.co/e2R2nFWHP7
June 30th 2019, 7:06am
OlympiaReport @OlympiaReport
ImmunoGen $IMGN Downgraded to “Strong Sell” at BidaskClub https://t.co/Q0PPD2va5Y
June 30th 2019, 1:06am
WeekHerald @WeekHerald
ImmunoGen $IMGN Downgraded to “Strong Sell” at BidaskClub https://t.co/OD36pHbOBY
June 30th 2019, 1:06am
ThisLincolnian @ThisLincolnian
ImmunoGen $IMGN Downgraded to “Strong Sell” at BidaskClub https://t.co/CTdO4q7Cc1
June 30th 2019, 1:06am
TheMarketsDaily @TheMarketsDaily
ImmunoGen, Inc. $IMGN Expected to Post Quarterly Sales of $10.33 Million https://t.co/jDZzRAzMOo
June 30th 2019, 12:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.